Similarly, other flavonoids such as 7,3′,4′-trihydroxyisoflavone, skullcapflavone II, and orobol have been reported to downregulate CCL17 and CCL22 expression both in mouse and HaCaT AD models. Here, CCL22 is linked to Alzheimer disease.